Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases

BACKGROUND: Although the clinical efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) in EGFR‐mutant non‐small cell lung cancer (NSCLC) patients has been demonstrated, their efficacy in EGFR‐mutant NSCLCs with central nervous system (CNS) metastases and the role of ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Saida, Yu, Watanabe, Satoshi, Abe, Tetsuya, Shoji, Satoshi, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Koyama, Kenichi, Miura, Satoru, Tanaka, Hiroshi, Okajima, Masaaki, Terada, Masaki, Ishida, Takashi, Tsukada, Hiroki, Makino, Masato, Iwashima, Akira, Sato, Kazuhiro, Matsumoto, Naoya, Yoshizawa, Hirohisa, Kikuchi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825912/
https://www.ncbi.nlm.nih.gov/pubmed/31507098
http://dx.doi.org/10.1111/1759-7714.13189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825912/
https://www.ncbi.nlm.nih.gov/pubmed/31507098
http://dx.doi.org/10.1111/1759-7714.13189

Ejemplares similares